38182 Federal Register / Vol. 63, No. 135 /Wednesday, July 15, 1998 / Notices

Inclusion of Women and Racial and

Ethnic Minorities in Research

It is the policy of the Centers for

Disease Control and Prevention (CDC)

and the Agency for Toxic Substances

and Disease Registry (ATSDR) to ensure

that individuals of both sexes and the

various racial and ethnic groups will be

included in CDC/ATSDR-supported

research projects involving human

subjects, whenever feasible and

appropriate. Racial and ethnic groups

are those defined in OMB Directive No.

15 and include American Indian or

Alaska Native, Asian, Black or African

American, Hispanic or Latino, Native

Hawaiian or Other Pacific Islander.

Applicants shall ensure that women,

racial and ethnic minority populations

are appropriately represented in

applications for research involving

human subjects. Where clear and

compelling rationale exist that inclusion

is inappropriate or not feasible, this

situation must be explained as part of

the application. This policy does not

apply to research studies when the

investigator cannot control the race,

ethnicity, and/or sex of subjects. Further

guidance to this policy is contained in

the Federal Register, Vol. 60, No. 179,

pages 47947–47951, and dated Friday,

September 15, 1995.

Application Submission and Deadline

The original and two copies of the

application PHS Form 5161–1 (Revised

5/96, OMB Number 0937–0189) must be

submitted to Sharron P. Orum, Grants

Management Officer, Procurement and

Grants Office, Centers for Disease

Control and Prevention (CDC), Room

300, Mail Stop E–18, 255 East Paces

Ferry Road, NE., Atlanta, GA 30305, on

or before August 15, 1998.

1. Deadline: Applications shall be

considered as meeting the deadline if

they are either:

(a) Received on or before the deadline

date; and

(b) Sent on or before the deadline date

and received in time for submission to

the objective review group. (Applicants

must request a legibly dated U.S. Postal

Service postmark or obtain a legibly

dated receipt from a commercial carrier

or U.S. Postal Service. Private metered

postmarks will not be accepted as proof

of timely mailing.)

2. Late Applications: Applications

that do not meet the criteria in 1.(a) and

1.(b) above are considered late

applications. Late applications will not

be considered in the current

competition and will be returned to the

applicant.

Where to Obtain Additional

Information

A complete program description and

information on application procedures

may be obtained in an application

package. Business management

technical assistance may be obtained

from Sharron Orum, Grants

Management Officer, Grants

Management Branch, Procurement and

Grants Office, Centers for Disease

Control and Prevention (CDC), Room

314, Mail Stop E–18, 255 East Paces

Ferry Road, NE., Atlanta, GA 30305;

telephone (404) 842–6508 or the

Internet at, slh3@cdc.gov. Programmatic

technical assistance may be obtained

from Rita Dı ́az-Kenney, Division of

Diabetes Translation, National Center

for Chronic Disease Prevention and

Health Promotion, Centers for Disease

Control and Prevention (CDC), Mail

Stop K–10, 4770 Buford Highway NE.,

Atlanta, GA 30341–3724; telephone

(770) 488–5016, or the Internet at:

rvd1@cdc.gov.

You may also obtain this

announcement, and other CDC

announcements, from one of two

Internet sites on the actual publication

date: CDC’s home-page at http://

www.cdc.gov or the Government

Printing Office home-page (including

free on-line access to the Federal

Register at http://www.access.gpo.gov).

Please refer to Announcement number

98082 when requesting information and

submitting an application.

Potential applicants may obtain a

copy of Healthy People 2000 (Full

Report; stock No. 017–001–00474–0) or

Healthy People 2000 (Summary Report;

stock No. 017–001–00473–1) referenced

in the Introduction through the

Superintendent of Documents,

Government Printing Office,

Washington, DC 20402–9325; telephone

(202) 512–1800.

Dated: July 9, 1998.

John L. Williams,

Director, Procurement and Grants Office,

Centers for Disease Control and Prevention

(CDC).

[FR Doc. 98–18824 Filed 7–14–98; 8:45 am]

BILLING CODE 4163–18–P

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Centers for Disease Control and

Prevention

Ethics Subcommittee and the Advisory

Committee to the Director, Centers for

Disease Control and Prevention:

Cancellation of Meetings

This notice announces the

cancellation of previously announced

meetings.

FEDERAL REGISTER CITATION OF PREVIOUS

ANNOUNCEMENT: 63 FR 34901, June 26,

1998.

PREVIOUSLY ANNOUNCED TIMES AND

DATES: 9 a.m.–3 p.m., July 16, 1998, and

8:30 a.m.–3 p.m. July 17, 1998.

CHANGE IN THE MEETING: These meetings

have been cancelled.

CONTACT PERSON FOR MORE INFORMATION:

Linda Kay McGowan, Executive

Secretary, Advisory Committee to the

Director, CDC, 1600 Clifton Road, NE,

M/S D–24, Atlanta, Georgia 30333,

telephone 404/639–7080.

Dated: July 10, 1998.

Nancy C. Hirsch,

Acting Director, Management Analysis and

Services Office, Centers for Disease Control

and Prevention (CDC).

[FR Doc. 98–18934 Filed 7–14–98; 8:45 am]

BILLING CODE 4163–18–P

DEPARTMENT OF HEALTH AND

HUMAN SERVICES

Food and Drug Administration

[FDA 225–98–800]

Memorandum of Understanding

Between the Food and Drug

Administration and the Indian Health

Service

AGENCY: Food and Drug Administration,

HHS.

ACTION: Notice.

SUMMARY: The Food and Drug

Administration (FDA) is providing

notice of a memorandum of

understanding (MOU) between FDA and

the Indian Health Service (IHS). The

purpose of the MOU is to develop a

more cohesive relationship to mutually

address American Indian and Alaska

Native issues within the context of each

organization’s jurisdiction.

DATES: The agreement became effective

July 9, 1997.

FOR FURTHER INFORMATION CONTACT:

Mary C. Wallace, Office of External

Affairs (HFE–3), Food and Drug

Administration, 5600 Fishers Lane,

Rockville, MD 20857, 301–827–4406.
Federal Register / Vol. 63, No. 135 /Wednesday, July 15, 1998 / Notices 38183

SUPPLEMENTARY INFORMATION: In

accordance with 21 CFR 20.108(c),

which states that all written agreements

and MOU’s between FDA and others

shall be published in the Federal

Register, the agency is publishing notice

of this MOU.

Dated: July 8, 1998.

William K. Hubbard,

Associate Commissioner for Policy

Coordination.

BILLING CODE 4160–01–F
38184 Federal Register / Vol. 63, No. 135 /Wednesday, July 15, 1998 / Notices
Federal Register / Vol. 63, No. 135 /Wednesday, July 15, 1998 / Notices 38185
38186 Federal Register / Vol. 63, No. 135 /Wednesday, July 15, 1998 / Notices
Federal Register / Vol. 63, No. 135 /Wednesday, July 15, 1998 / Notices 38187
38188 Federal Register / Vol. 63, No. 135 /Wednesday, July 15, 1998 / Notices

[FR Doc. 98–18829 Filed 7–14–98; 8:45 am]

BILLING CODE 4160–01–C